Answer
No, Fabhalta 200 mg hard capsules (iptacopan) are not recommended for patients with severe hepatic impairment (Child-Pugh class C).
Sources for this answer
- FABHALTA 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked